Details for New Drug Application (NDA): 061841
✉ Email this page to a colleague
NDA 061841 describes TERRAMYCIN W/ POLYMYXIN, which is a drug marketed by Pfizer and Casper Pharma Llc and is included in two NDAs. Additional details are available on the TERRAMYCIN W/ POLYMYXIN profile page.
The generic ingredient in TERRAMYCIN W/ POLYMYXIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
The generic ingredient in TERRAMYCIN W/ POLYMYXIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
Summary for 061841
| Tradename: | TERRAMYCIN W/ POLYMYXIN |
| Applicant: | Pfizer |
| Ingredient: | oxytetracycline hydrochloride; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OTIC | Strength | EQ 5MG BASE/GM;10,000 UNITS/GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
